ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure — A network meta-analysis-Reference-Cited by-同舟云学术

ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure — A network meta-analysis

Published:2016-08 Issue: Volume:217 Page:128-134
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Ricci Fabrizio,Di Castelnuovo Augusto,Savarese Gianluigi,Perrone Filardi Pasquale,De Caterina Raffaele

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference60 articles.

1. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The task force on ACE-inhibitors of the European Society of Cardiology;Lopez-Sendon;Eur. Heart J.,2004

2. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials;Dagenais;Lancet,2006

3. 2007 guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC);Mancia;Eur. Heart J.,2007

4. Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?;Ruschitzka;Eur. Heart J.,2012

5. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review;Ferrari;Expert. Rev. Cardiovasc. Ther.,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension;Global Heart;2024

2. Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction;PLOS ONE;2023-03-09

3. Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations;Vascular Health and Risk Management;2022-07

4. Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study;Hypertension;2021-09

5. ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction;Indian Heart Journal;2020-09